Literature DB >> 18264677

Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.

Emmanouil S Hatzipantelis, Nikolaos Gombakis, Vasiliki Sidi, Evgenia Papakonstantinou, Dimitrios E Koliouskas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18264677     DOI： 10.1007/s11739-008-0104-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  13 in total

1.  Treatment of traumatic bleeding with recombinant factor VIIa.

Authors:  G Kenet; R Walden; A Eldad; U Martinowitz
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

Review 2.  Recombinant factor VIIa (Novoseven) and the safety of treatment.

Authors:  H R Roberts
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

Review 3.  A cell-based model of coagulation and the role of factor VIIa.

Authors:  Maureane Hoffman
Journal:  Blood Rev       Date:  2003-09       Impact factor: 8.250

4.  Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.

Authors:  Philip W Friederich; Christiaan P Henny; Embert J Messelink; Mark G Geerdink; Tymen Keller; Karl-Heinz Kurth; Harry R Büller; Marcel Levi
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

5.  Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.

Authors:  U Martinowitz; M Michaelson
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

6.  Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.

Authors:  Ruby Anne E Deveras; Craig M Kessler
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

7.  Recombinant activated factor VII for adjunctive hemorrhage control in trauma.

Authors:  U Martinowitz; G Kenet; E Segal; J Luboshitz; A Lubetsky; J Ingerslev; M Lynn
Journal:  J Trauma       Date:  2001-09

Review 8.  The use of recombinant factor VIIa in the treatment of bleeding disorders.

Authors:  Harold R Roberts; Dougald M Monroe; Gilbert C White
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

Review 9.  Recombinant factor VIIa (NovoSeven) as a hemostatic agent.

Authors:  Ulla Hedner
Journal:  Dis Mon       Date:  2003-01       Impact factor: 3.800

Review 10.  Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.

Authors:  Mike Grounds
Journal:  Blood Rev       Date:  2003-09       Impact factor: 8.250
View more
  1 in total

1.  Effectiveness of recombinant activated factor VII in haemorragic cancer-related disseminated intravascular coagulation: a case report.

Authors:  Matteo Giorgi Pierfranceschi; Davide Imberti; Sergio Orlando; Daniele Vallisa; Emanuele Michieletti
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.